NAPPSA Resource Library
Oncology Intelligence
Collection integrating oncology therapeutics, immunotherapy, targeted therapy, biomarkers, FDA oncology updates, clinical trials, precision medicine, and AJPPS research.
AJPPS Research
Browse published research in AJPPS. Use the journal’s search to find articles relevant to this field.
Latest Oncology Intelligence
For recent reporting, visit News & Updates. Check the original source and publication date before applying information to practice.
FDA & Regulatory Updates
- October 30, 2026: Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Announcement - 10/30/2026
by FDA on 10/23/2026 at 10:27 pmOctober 30, 2026: Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Announcement
- FDA Rare Disease Day 2027 - 03/05/2027by FDA on 10/23/2026 at 8:35 pm
The FDA will host Rare Disease Day (RDD), a hybrid public meeting, on Friday, March 5, 2027 in global observance of Rare Disease Week. The theme is: “Your stories. Our stories. An Event for Patients.”
- GDUFA Paid Facilities Listby FDA on 10/23/2026 at 7:46 pm
This list contains GDUFA facility payments received by the Agency. Data are extract from the User Fee System and GDUFA Facility User Fee Coversheets. The following table explains the terms used in the list:
- What's New Related to Drugsby FDA on 10/23/2026 at 6:09 pm
Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.
- Notable Approvals | Drugsby FDA on 10/23/2026 at 6:04 pm
News about human drug-related approvals
Clinical Trials Watch
Search ClinicalTrials.gov by condition, intervention, location, and recruitment status. Confirm study details with the study team.
Educational Resources
Browse NAPPSA education and events. Check each activity for dates and availability.
Related Collections
- Biotechnology & Gene Therapy Intelligence
- Pharmacogenomics Intelligence
- FDA Approvals & Medication Safety